Our observation that TPMT protein concentrations were reduced in PACSIN2 KD cells is concordant with our previous reports that PACSIN2 modulates TPMT activity in patients with ALL (Stocco et al, 2012). Here, TPMT is linked to acute lymphoblastic leukemia.